Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: Oncogene. 2018 Mar 15;37(23):3151–3165. doi: 10.1038/s41388-018-0178-3

Figure 1. miR-21 expression is associated with decreased survival in 6 patient cohorts identified in the TCGA database.

Figure 1

(a) Glioblastoma multiforme; (b) Renal clear cell carcinoma; (c) Low grade glioma; (d) Hepatocellular carcinoma; (e) Lung adenocarcinoma; (f) Pancreatic adenocarcinoma. Kaplan–Meier results were analyzed by log-rank test. *P ≤ 0.05, ***P ≤ 0.001.

HHS Vulnerability Disclosure